Agouni A

ORCID: 0000-0002-8363-1582 · 1 paper in corpus

2024

Advances in nanotechnology-enabled drug delivery for combining PARP inhibitors and immunotherapy in advanced ovarian cancer.

Biomolecules & biomedicine ·doi:10.17305/bb.2023.9757

Advanced ovarian cancer is a malignancy that spreads beyond the ovaries to the pelvis, abdomen, lungs, or lymph nodes. Effective treatment options are available to improve survival rates in patients with advanced ovarian cancer. These inclu…